Valuation: Nexentis Technologies Inc.

Market Cap 1.13M 995K 929K 852K 1.6M 108M 1.63M 11.01M 4.31M 53.66M 4.25M 4.16M 186M P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value -1.95M -1.71M -1.6M -1.47M -2.74M -186M -2.81M -18.93M -7.4M -92.27M -7.31M -7.15M -319M EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
78.83%
Yield 2024 *
-
Yield 2025 -
1 day-5.16%
1 week-28.64%
Current month-65.89%
1 month-68.52%
3 months-68.72%
6 months-83.33%
Current year-87.50%
1 week 1.43
Extreme 1.4301
2
1 month 1.43
Extreme 1.4301
4.57
Current year 1.43
Extreme 1.4301
23.8
1 year 1.43
Extreme 1.4301
61.74
3 years 1.43
Extreme 1.4301
4,047.41
5 years 1.43
Extreme 1.4301
16,995.68
10 years 1.43
Extreme 1.4301
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 04/11/2020
Director of Finance/CFO 39 17/04/2022
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 53 25/08/2020
Chairman 62 23/05/2021
Director/Board Member 54 25/08/2020
Date Insider Type Main position Quantity % Market Cap.
09/02/26 Free

Chairman

116,286 4.3350%
09/02/26 Free

Controller

50,000 1.8639%
09/02/26 Free

Chief Financial Officer

50,000 1.8639%
Change 5-day change 1-year change 3-year change Capi.($)
-5.16%-28.64%-97.54%-99.85% 1.13M
+1.51%+1.88%+23.75%+59.83% 59.49B
+0.11%-.--%-.--%-.--% 12.96B
+2.36%+1.68%+24.65%+167.36% 10.44B
+1.67%+3.64%+21.01%+61.31% 7.92B
-2.00%-3.38%-23.05%-23.17% 6.76B
+1.16%-0.83%-11.30%+73.29% 5.53B
+1.75%-1.40%-16.45%-2.48% 5.29B
+0.54%+2.28%+23.94%+33.92% 4.78B
+1.67%+2.68%-33.04%-23.17% 4.3B
Average +0.36%-2.49%-8.80%+24.70% 11.75B
Weighted average by Cap. +1.18%+1.23%+12.80%+51.84%

Financials

2024 2025
Net sales 210K 185K 172K 158K 296K 20.11M 303K 2.04M 799K 9.95M 788K 771K 34.41M -
Net income -5.19M -4.56M -4.26M -3.91M -7.32M -497M -7.5M -50.51M -19.75M -246M -19.5M -19.07M -851M -4M -3.52M -3.28M -3.01M -5.64M -384M -5.78M -38.94M -15.23M -190M -15.03M -14.71M -656M
Net Debt -2.48M -2.18M -2.04M -1.87M -3.5M -238M -3.59M -24.17M -9.45M -118M -9.33M -9.13M -407M -3.08M -2.71M -2.53M -2.32M -4.34M -295M -4.45M -29.95M -11.71M -146M -11.56M -11.31M -505M
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
29/07/26 US$1.470 -5.16% 35,783
28/07/26 US$1.550 -7.19% 610,502
27/07/26 US$1.670 -7.22% 34,014
24/07/26 US$1.800 -5.76% 18,970
23/07/26 US$1.910 -7.28% 51,275
  1. Stock Market
  2. Stocks
  3. NXTS Stock